Metro Biotech(PRIVATE)
A biotech firm developing pharmaceutical-grade NAD+ precursors.
1 Insight
Investment Insights
AI-generated insights about Metro Biotech from various financial sources
Tuesday, February 24, 2026
Very Bullish
Running five clinical trials on MIB-626 (NMN) for conditions like Alzheimer's to move the substance from supplement to FDA-approved drug.
Tuesday, February 24, 2026
Very Bullish
Running five clinical trials on MIB-626 (NMN) for conditions like Alzheimer's to move the substance from supplement to FDA-approved drug.